OrganoClick AB (publ) (FRA:0CF)

OrganoClick AB Statistics

Total Valuation

OrganoClick AB has a market cap or net worth of EUR 16.79 million. The enterprise value is 23.76 million.

Market Cap	16.79M
Enterprise Value	23.76M

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	110.00M
Shares Outstanding	n/a
Shares Change (YoY)	+0.91%
Shares Change (QoQ)	+3.13%
Owned by Insiders (%)	35.26%
Owned by Institutions (%)	14.12%
Float	60.17M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.70
PB Ratio	4.62
P/TBV Ratio	26.15
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-9.97
EV / Sales	2.39
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-29.84

Financial Position

The company has a current ratio of 0.70, with a Debt / Equity ratio of 1.86.

Current Ratio	0.70
Quick Ratio	0.27
Debt / Equity	1.86
Debt / EBITDA	n/a
Debt / FCF	-8.50
Interest Coverage	-3.11

Financial Efficiency

Return on equity (ROE) is -61.70% and return on invested capital (ROIC) is -11.86%.

Return on Equity (ROE)	-61.70%
Return on Assets (ROA)	-8.12%
Return on Invested Capital (ROIC)	-11.86%
Return on Capital Employed (ROCE)	-27.27%
Revenue Per Employee	247,053
Profits Per Employee	-59,587
Employee Count	40
Asset Turnover	0.72
Inventory Turnover	2.62

Taxes

In the past 12 months, OrganoClick AB has paid 17,276 in taxes.

Income Tax	17,276
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -36.15% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-36.15%
50-Day Moving Average	0.12
200-Day Moving Average	0.15
Relative Strength Index (RSI)	50.19
Average Volume (20 Days)	n/a

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, OrganoClick AB had revenue of EUR 9.88 million and -2.38 million in losses. Loss per share was -0.02.

Revenue	9.88M
Gross Profit	2.00M
Operating Income	-1.79M
Pretax Income	-2.39M
Net Income	-2.38M
EBITDA	-1.25M
EBIT	-1.79M
Loss Per Share	-0.02

Balance Sheet

The company has 482,736 in cash and 6.77 million in debt, giving a net cash position of -6.29 million.

Cash & Cash Equivalents	482,736
Total Debt	6.77M
Net Cash	-6.29M
Net Cash Per Share	n/a
Equity (Book Value)	3.64M
Book Value Per Share	0.03
Working Capital	-2.28M

Cash Flow

In the last 12 months, operating cash flow was -592,815 and capital expenditures -203,333, giving a free cash flow of -796,148.

Operating Cash Flow	-592,815
Capital Expenditures	-203,333
Free Cash Flow	-796,148
FCF Per Share	n/a

Margins

Gross margin is 20.19%, with operating and profit margins of -18.10% and -24.12%.

Gross Margin	20.19%
Operating Margin	-18.10%
Pretax Margin	-24.18%
Profit Margin	-24.12%
EBITDA Margin	-12.69%
EBIT Margin	-18.10%
FCF Margin	n/a

Dividends & Yields

OrganoClick AB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.91%
Shareholder Yield	-0.91%
Earnings Yield	-14.20%
FCF Yield	-4.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

OrganoClick AB has an Altman Z-Score of -1.36 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.36
Piotroski F-Score	1